Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 0.00 (-2.12%)
At close: Oct 21, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Total Current Liabilities (2011 - 2026)

Updated

Vistagen Therapeutics (VTGN) posted Total Current Liabilities of $11.19 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 0.3% from $11.16 million a year earlier but down 12.5% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Total Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Total Current Liabilities came in at $12.8 million, up 1.5% from FY2025.

  • Annual Total Current Liabilities has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 25.0% (FY2021 to FY2026).
  • In prior fiscal years, Vistagen Therapeutics' Total Current Liabilities was $12.61 million in FY2025 (+146.2%), $5.12 million in FY2024 (+12.0%), $4.57 million in FY2023 (-20.7%) and $5.77 million in FY2022 (+37.6%).
  • Quarterly Total Current Liabilities has run from a low of $2.91 million in fiscal Q2 2024 to a high of $13.64 million in fiscal Q2 2026 over five years.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last ten quarters, with growth averaging 79.8% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was fiscal Q2 2025, with growth of 158.6%; the weakest was fiscal Q1 2024, with a decline of 54.6%.
  • According to Business Quant data, Total Current Liabilities for the three prior fiscal quarters was $12.8 million (Q4 2026), $13.53 million (Q3 2026) and $13.64 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Vistagen Therapeutics 8.39 Mn -207.68 Mn - 11.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.19 Mn
Mar 31, 2026 12.80 Mn
Dec 31, 2025 13.53 Mn
Sep 30, 2025 13.64 Mn
Jun 30, 2025 11.16 Mn
Mar 31, 2025 12.61 Mn
Dec 31, 2024 9.62 Mn
Sep 30, 2024 7.52 Mn
Jun 30, 2024 6.24 Mn
Mar 31, 2024 5.12 Mn
Dec 31, 2023 4.16 Mn
Sep 30, 2023 2.91 Mn
Jun 30, 2023 4.05 Mn
Mar 31, 2023 4.57 Mn
Dec 31, 2022 4.29 Mn
Sep 30, 2022 6.05 Mn
Jun 30, 2022 8.93 Mn
Mar 31, 2022 5.77 Mn
Dec 31, 2021 6.42 Mn
Sep 30, 2021 7.91 Mn
API Access

Vistagen Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=VTGN&period=max&api_key=YOUR_API_KEY